文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛消化、代谢与肾脏急症

简化合并症评估预测COVID-19临床结局的验证——一项多中心回顾性观察研究

Validation of a simplified comorbidity evaluation predicting clinical outcomes among patients with coronavirus disease 2019 - A multicenter retrospective observation study.
PubMed 文献 · Am J Emerg Med · 2022-03-10
一句话结论在6家急诊科22248例患者中,简化合并症评估与COVID-19住院、ICU入住、有创机械通气和院内死亡相关,预测院内死亡不劣于Charlson合并症指数。

该多中心回顾性观察研究纳入2020年6家医院急诊科所有接受SARS-CoV-2 PCR检测的患者共22248例,其中7023例(32%)COVID-19阳性。按美国三波疫情(第一波2020年3-5月、第二波2020年6-9月、第三波2020年10-12月)分组,用多因素logistic回归评估简化合并症评估作为独立危险因素预测临床结局。结果显示三波疫情中,合并三种以上慢性病的COVID-19患者住院、ICU入住、接受有创机械通气和院内死亡比例均更高。简化合并症评估与COVID临床结局相关,预测院内死亡不劣于Charlson合并症指数。

要点

  • 6家急诊科22248例受检者中7023例(32%)COVID-19阳性,按三波疫情分组分析。
  • 三波疫情中,合并三种以上慢性病的COVID-19患者住院、ICU入住、有创机械通气和院内死亡比例均更高。
  • 简化合并症评估作为独立危险因素与COVID临床结局相关,预测院内死亡不劣于Charlson合并症指数。
  • 研究为多中心回顾性观察,纳入2020年6家医院急诊科全部SARS-CoV-2 PCR检测患者。

适用人群与场景

  • 2020年在美国6家不同医院急诊科接受SARS-CoV-2 PCR检测的全部患者,共22248例,其中7023例(32%)COVID-19阳性。
  • 按美国疫情波次分为三组:第一波2020年3-5月、第二波2020年6-9月、第三波2020年10-12月。

研究设计与关键结果

  • 多中心回顾性观察研究,纳入2020年6家医院急诊科接受SARS-CoV-2 PCR检测的患者22248例,COVID-19阳性7023例(32%)。
  • 采用多因素logistic回归,将简化合并症评估作为独立危险因素预测临床结局。
  • 三波疫情中,合并三种以上慢性病的COVID-19患者住院、ICU入住、接受有创机械通气和院内死亡的比例均更高。
  • 简化合并症评估与COVID临床结局相关,预测院内死亡不劣于Charlson合并症指数。

证据类型、等级与局限

  • 多中心回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为简化合并症评估可用于预测COVID-19临床结局,其预测院内死亡不劣于Charlson合并症指数。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: We compared and validated the performance accuracy of simplified comorbidity evaluation compared to the Charlson Comorbidity Index (CCI) predicting COVID-19 severity. In addition, we also determined whether risk prediction of COVID-19 severity changed during different COVID-19 pandemic outbreaks.

METHODS: We enrolled all patients whose SARS-CoV-2 PCR tests were performed at six different hospital Emergency Departments in 2020. Patients were divided into three groups based on the various COVID-19 outbreaks in the US (first wave: March-May 2020, second wave: June-September 2020, and third wave: October-December 2020). A simplified comorbidity evaluation was used as an independent risk factor to predict clinical outcomes using multivariate logistic regressions.

RESULTS: A total of 22,248 patients were included, for which 7023 (32%) patients tested COVID-19 positive. Higher percentages of COVID-19 patients with more than three chronic conditions had worse clinical outcomes (i.e., hospital and intensive care unit admissions, receiving invasive mechanical ventilations, and in-hospital mortality) during all three COVID-19 outbreak waves.

CONCLUSIONS: This simplified comorbidity evaluation was validated to be associated with COVID clinical outcomes. Such evaluation did not perform worse when compared with CCI to predict in-hospital mortality.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. d'Etienne JP, Alanis N, Chou E, et al. Validation of a simplified comorbidity evaluation predicting clinical outcomes among patients with coronavirus disease 2019 - A multicenter retrospective observation study. Am J Emerg Med. 2022. PMID: 35366439. doi:10.1016/j.ajem.2022.03.011

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。